Key Highlights
- Shares of Infleqtion climbed 8.3% to $13.59 following Citi’s decision to increase its price target from $20 to $22 while maintaining a Buy recommendation.
- Wall Street analysts hold a “Moderate Buy” consensus with an average price forecast of $20.60.
- The quantum technology firm fell short of Q2 earnings projections, posting a $0.11 per share loss versus expectations of $0.07.
- Company insiders divested approximately 4 million shares totaling $64.8 million in the last three-month period.
- Multiple institutional investors established fresh positions during Q2, with S&G Foundation acquiring $154 million in shares.
Shares of Infleqtion (INFQ) experienced an impressive 8.3% surge on Friday, settling at $13.59, following Citi’s announcement that it was elevating its price objective for the quantum technology specialist from $20 to $22 while maintaining its Buy recommendation.
During Friday’s session, shares peaked at $13.61. Approximately 4.6 million shares changed hands, representing a 52% decline compared to the typical daily volume of 9.67 million shares.
The increased price target from Citi suggests the financial institution anticipates additional growth potential for Infleqtion. The maintained Buy recommendation indicates the firm continues to consider the shares an appealing investment at present valuations.
Wall Street’s Perspective
Citi isn’t alone in its optimistic outlook. Wedbush launched coverage on August 3rd, assigning an Outperform rating alongside a $20 price objective. Craig Hallum entered the conversation in July with a Buy recommendation and $19 target.
Zacks Research elevated the stock to Hold status in late June. Conversely, Weiss Ratings initiated coverage with a Sell recommendation in May.
The current breakdown shows one Strong Buy rating, five Buy recommendations, one Hold, and one Sell. This translates to a “Moderate Buy” consensus with an average price objective of $20.60.
The shares trade above their 50-day moving average of $11.77, while the company maintains a market capitalization near $3.02 billion. The negative PE ratio of -92.13 indicates the company remains unprofitable.
Quarterly Results and Executive Stock Sales
Infleqtion unveiled its Q2 results on August 12th. The firm recorded a per-share loss of $0.11, falling short of the Street’s $0.07 loss estimate by $0.04. Quarterly revenue reached $13.54 million.
Wall Street currently projects full-year earnings per share of -$0.24 for Infleqtion.
Regarding insider transactions, CEO Matthew Kinsella divested 112,065 shares on May 26th at an average of $15.56 per share, generating approximately $1.74 million in proceeds. This transaction reduced his stake by 25%.
Chief Revenue Officer Paul Lipman simultaneously sold 100,000 shares at $15.83 each, totaling $1.58 million. This sale represented a 50% decrease in his direct ownership.
Collectively, company insiders unloaded more than 4 million shares worth $64.8 million during the past three months.
While insiders were reducing positions, institutional investors demonstrated growing interest. S&G Foundation established a significant new position valued at $154 million in Q2. Davis Asset Management initiated a $27.8 million stake. Wellington Management contributed $3.7 million, and Bank of New York Mellon expanded its holdings by more than 1,350%.
Year-to-date, Infleqtion’s stock has declined 19.55%, and technical indicators currently flash a Strong Sell signal.
Based on the most recent data, the company’s market capitalization stands at approximately $2.82 billion.


